Profile
Full Name
MaxCyte, Inc.Ticker Symbol
MXCTExchange
NASDAQSector
HealthcareIndustry
Medical DevicesCountry
United StatesIPO
July 30, 2021Indexes
Not includedWebsite
http://www.maxcyte.comEmployees
114Key Details
Price
$2.58(+10.26%)
Market cap
$273.55M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$38.63M(-6.44% YoY)
Annual EPS
-$0.39(-5.41% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
MaxCyte doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 12, 25 Stifel
BuyApr 23, 24 Stephens & Co.
OverweightMar 13, 24 Stephens & Co.
OverweightMar 13, 24 BTIG
BuyNov 29, 23 Craig-Hallum
BuyOct 5, 23 Stephens & Co.
OverweightMar 28, 23 Stephens & Co.
OverweightAug 15, 22 BTIG
BuyAug 24, 21 William Blair
OutperformAug 24, 21 Stifel
BuyInstitutional Ownership
- What is the ticker symbol for MaxCyte?
- Does MaxCyte pay dividends?
- What sector is MaxCyte in?
- What industry is MaxCyte in?
- What country is MaxCyte based in?
- When did MaxCyte go public?
- Is MaxCyte in the S&P 500?
- Is MaxCyte in the NASDAQ 100?
- Is MaxCyte in the Dow Jones?
- When was MaxCyte's last earnings report?
- When does MaxCyte report earnings?
- Should I buy MaxCyte stock now?
What is the ticker symbol for MaxCyte?
The ticker symbol for MaxCyte is NASDAQ:MXCT
Does MaxCyte pay dividends?
No, MaxCyte does not pay dividends
What sector is MaxCyte in?
MaxCyte is in the Healthcare sector
What industry is MaxCyte in?
MaxCyte is in the Medical Devices industry
What country is MaxCyte based in?
MaxCyte is headquartered in United States
When did MaxCyte go public?
MaxCyte's initial public offering (IPO) was on July 30, 2021
Is MaxCyte in the S&P 500?
No, MaxCyte is not included in the S&P 500 index
Is MaxCyte in the NASDAQ 100?
No, MaxCyte is not included in the NASDAQ 100 index
Is MaxCyte in the Dow Jones?
No, MaxCyte is not included in the Dow Jones index
When was MaxCyte's last earnings report?
MaxCyte's most recent earnings report was on Mar 11, 2025
When does MaxCyte report earnings?
The next expected earnings date for MaxCyte is May 7, 2025
Should I buy MaxCyte stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions